Drug intelligence / Profile preview

salbutamol + hypertonic saline

Development stage
Unknown
Modality
Small Molecules
Administration
Inhalation
01

Overview

Salbutamol + hypertonic saline is a combination therapy used primarily as an inhaled (nebulized) treatment for respiratory conditions such as bronchiolitis and cystic fibrosis. Salbutamol (also known as albuterol) is a short-acting beta-2 adrenergic receptor agonist that acts as a bronchodilator, relaxing airway smooth muscle to relieve bronchospasm. Hypertonic saline (commonly 3% or higher concentration sodium chloride solution) works by drawing water into the airway lumen, thinning mucus and enhancing mucociliary clearance. The combination aims to provide both bronchodilation and improved mucus clearance, potentially reducing symptoms like wheezing, cough, and breathlessness in patients with obstructive airway diseases[6][7][5]. Clinical studies indicate that this combination is safe and effective for mild to moderate bronchiolitis; however, some evidence suggests it may not offer significant additive benefit over either agent alone in certain populations[1][6].

Other names
hypertonic saline and salbutamolnebulized hypertonic saline/salbutamol solution
02

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on salbutamol + hypertonic saline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salbutamol + hypertonic saline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call